The Aspertame Lawsuit (Equal Sugar Sweetener Is Toxic!), page 1

Alright, so instead of doing the (ya'll guessed it) disinfo campaigning for Nestle or whatev big-industry that junk is owned by, I, differing from your approach, will continue w/ said research, not just some sentence by sentence taking apart language like the semantics majors you are.

This site is a good one for general truths about said topic. They warn public of aspartame.org as a propaganda-special interest site.

HERE is a site that's called, hmm, the Center for Science in the Public Interest, let's see what they gotta say about this topic:

Center for Science in the Public Interest

For Immediate Release: July 27, 2005

Aspartame: New Study Renews Cancer Concern, Says CSPI

Consumers & Manufacturers Should Switch to Sucralose Pending Thorough Government Safety Tests

The Food and Drug Administration should immediately review the safety of the artificial sweetener aspartame, and possibly ban it, in light of a new study published in the European Journal of Oncology. The study, conducted in Italy, found statistically significant increases in lymphomas and leukemias among female rats given aspartame. The smallest amount of aspartame (20 milligrams per kilogram of body weight) that caused a significant increase in cancer incidence is in the ballpark of what many people consume. The study also found equivocal results regarding brain tumors.

At a minimum, the government should conduct new animal studies of aspartame and encourage consumers and manufacturers that use artificial sweeteners to switch to sucralose, which CSPI considers to be the safest of the several artificial sweeteners on the market.

Aspartame, also sold as Equal and NutraSweet, is used in Diet Coke, Diet Pepsi, and thousands of other foods and is consumed by 200 million people in the United States and around the world, according to the industry's Calorie Control Council.

"The FDA immediately should ask the government's National Toxicology Program to conduct new animal studies to assess the cancer risk from aspartame. As a precautionary measure, in the several years it would take to design and conduct such studies, the FDA should consider ordering aspartame off the market," said CSPI executive director Michael F. Jacobson. "Despite several shortcomings in the new study, one notable plus is that it was designed and conducted independently. Virtually all of the previous research was sponsored by the makers of aspartame."